• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparative analysis of immune-related adverse events among patients with melanoma on immune checkpoint inhibitors: a retrospective cohort study.

作者信息

Pan Catherina X, Kim Daniel Y, Lau Charles B, Lau William C, Rowley Rachael, Kanwar Ruhi, LeBoeuf Nicole R, Nambudiri Vinod E

机构信息

Harvard Medical School, Boston, MA, USA.

Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.

出版信息

Br J Dermatol. 2023 Oct 25;189(5):637-640. doi: 10.1093/bjd/ljad271.

DOI:10.1093/bjd/ljad271
PMID:37503686
Abstract
摘要

相似文献

1
Comparative analysis of immune-related adverse events among patients with melanoma on immune checkpoint inhibitors: a retrospective cohort study.
Br J Dermatol. 2023 Oct 25;189(5):637-640. doi: 10.1093/bjd/ljad271.
2
Female sex is associated with higher rates of dermatologic adverse events among patients with melanoma receiving immune checkpoint inhibitor therapy: A retrospective cohort study.在接受免疫检查点抑制剂治疗的黑色素瘤患者中，女性发生皮肤不良事件的几率更高：一项回顾性队列研究。
J Am Acad Dermatol. 2022 Aug;87(2):403-406. doi: 10.1016/j.jaad.2021.06.885. Epub 2021 Jul 10.
3
Association of Anti-Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic Melanoma.抗程序性细胞死亡蛋白 1 抗体治疗与转移性黑色素瘤患者接受伊匹单抗免疫相关不良反应后毒性作用复发风险的相关性。
JAMA Dermatol. 2020 Sep 1;156(9):982-986. doi: 10.1001/jamadermatol.2020.2149.
4
Systematic review and meta-analysis efficacy and safety of immune checkpoint inhibitors in advanced melanoma patients with anti-PD-1 progression: a systematic review and meta-analysis.系统评价和荟萃分析抗 PD-1 进展的晚期黑色素瘤患者中免疫检查点抑制剂的疗效和安全性：系统评价和荟萃分析。
Clin Transl Oncol. 2021 Sep;23(9):1885-1904. doi: 10.1007/s12094-021-02598-6. Epub 2021 Apr 20.
5
Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma.晚期黑色素瘤患者接受免疫检查点抑制剂治疗期间血清乳酸脱氢酶与皮肤免疫相关不良事件的关联
J Am Acad Dermatol. 2022 Nov;87(5):1147-1149. doi: 10.1016/j.jaad.2022.02.024. Epub 2022 Feb 19.
6
Management of immune-related hepatitis in patients being treated with checkpoint inhibitors for metastatic melanoma, a review and case series.免疫相关肝炎在接受检查点抑制剂治疗转移性黑色素瘤患者中的管理：综述和病例系列。
J Oncol Pharm Pract. 2023 Jul;29(5):1163-1171. doi: 10.1177/10781552221103548. Epub 2022 May 23.
7
Immune checkpoint inhibitors-associated risk of immune-related hypothyroidism in older patients with advanced melanoma: a real-world analysis of US SEER-Medicare data.免疫检查点抑制剂相关的免疫相关性甲状腺功能减退风险在老年晚期黑色素瘤患者中：来自美国 SEER-Medicare 数据的真实世界分析。
Expert Opin Drug Saf. 2021 Apr;20(4):489-497. doi: 10.1080/14740338.2021.1877272. Epub 2021 Jan 25.
8
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study.伊匹木单抗单药治疗或伊匹木单抗联合抗PD-1治疗转移性黑色素瘤患者对抗PD-(L)1单药治疗耐药：一项多中心、回顾性队列研究。
Lancet Oncol. 2021 Jun;22(6):836-847. doi: 10.1016/S1470-2045(21)00097-8. Epub 2021 May 11.
9
Comparative efficacy and safety of immune checkpoint inhibitors for unresectable advanced melanoma: A systematic review and network meta-analysis.免疫检查点抑制剂用于不可切除的晚期黑色素瘤的疗效和安全性比较：一项系统评价和网状Meta分析。
Int Immunopharmacol. 2023 Feb;115:109657. doi: 10.1016/j.intimp.2022.109657. Epub 2023 Jan 4.
10
Vogt-Koyanagi-Harada-like syndrome induced by immune checkpoint inhibitors in a patient with melanoma.免疫检查点抑制剂诱发黑色素瘤患者出现类伏格特-小柳-原田综合征
Clin Exp Dermatol. 2020 Oct;45(7):908-911. doi: 10.1111/ced.14282. Epub 2020 Jul 5.